What Is An Impella?

Impella® is a percutaneous axial heart pump placed retrograde across the aortic valve into the left ventricle (LV) utilizing fluoroscopy +/- echocardiography. Its indications include high risk percutaneous coronary intervention (PCI, especially in cardiogenic shock or signs of ongoing ischemia), post-cardiotomy failure, and myocarditis. It is routinely used as a bridge between other forms of circulatory support like intra-aortic balloon pumps (IABP), ventricular assist devices (VAD), artificial hearts, and extracorporeal membrane oxygenation (ECMO). In 2014, the (underpowered) RECOVER RIGHT study showed benefits with the Impella RP device to help those with right-sided heart failure refractory to medical therapy. For the purposes of this post, I’ll only discuss the traditional left-sided Impella.

Without going into detail about the different power settings (P1 – P8), purge system, and other parameters, the intracardiac portion of the Impella consists of a pigtail to stabilize the catheter in the ventricle, an inflow where blood is suctioned from the LV, a radiopaque marker which is aligned with the aortic valve annulus under fluoroscopy, an outflow segment which propels blood into the ascending aorta, and a motor housing.

This device accomplishes many hemodynamic goals:

  • reduces left ventricular end diastolic pressure (LVEDP) and volume (preload)
  • reduces afterload
  • reduces myocardial oxygen demand
  • increases overall forward flow and mean arterial pressure (MAP)
  • increases coronary perfusion

Impellas traditionally come in three flavors:

  • Impella 2.5 (9 French catheter, 12 French motor) has a peak flow of 2.5 liters/minute and can be placed into the LV from the femoral artery
  • Impella CP (9 French catheter, 14 French motor) has a peak flow of 4.3 liters/minute and can also be placed from the femoral artery
  • Impella 5.0 (9 French catheter, 22 French motor) has a peak flow of 5.0 liters/minute but requires surgical placement (femoral artery cutdown, subclavian artery graft, etc.)

What I find interesting is this statement from ABIOMED’s website regarding the indications and duration for these devices:

The Impella 2.5™, Impella CP®, Impella 5.0™ and Impella LD™ catheters, in conjunction with the Automated Impella Controller, are temporary ventricular support devices intended for short term use (≤ 4 days for the Impella 2.5 and Impella CP, and ≤ 6 days for the Impella 5.0 and LD) and indicated for the treatment of ongoing cardiogenic shock that occurs immediately (< 48 hours) following acute myocardial infarction or open heart surgery as a result of isolated left ventricular failure that is not responsive to optimal medical management and conventional treatment measures.*  The intent of the Impella system therapy is to reduce ventricular work and to provide the circulatory support necessary to allow heart recovery and early assessment of residual myocardial function.

* Optimal medical management and convention treatment measures include volume loading and use of pressors and inotropes, with or without IABP.

Sometimes we’ll use Impella devices as ventricular vents for patients on ECMO for many weeks. In other situations, patients will have them for longer than 4-6 days as their native heart function slowly recovers.

Placing these devices can lead to vascular injury, bleeding (from placement and because we need to heparinize), intracardiac injury (especially of the aortic valve and papillary muscles). The axial pump can “chew up” cells at higher speeds leading to some degree of hemolysis and thrombocytopenia. Additionally, microemboli and plaques can be dislodged leading to renal dysfunction, strokes, etc.

With this in mind, a few contraindications to Impella placement include a mechanical aortic valve, significant aortic stenosis/insufficiency, LV thrombus/rupture, cardiac tamponade, and severe peripheral artery disease.

I’m definitely a fan of axillary Impellas since patients can still ambulate, but femoral Impellas are very finicky with regards to positioning. Because the inflow and outflow segments have to be properly positioned, if the patient moves his or her hip even slightly, they may move the catheter tip resulting in decreased cardiac output and suction events along the ventricular wall, valve, or chordae.

Drop me a comment below with questions! 🙂

You might also like

Leave A Reply

Your email address will not be published.

6 Comments
  1. Sharon says

    Always learn something, and so interesting Rishi. Thanks?

    1. Rishi says

      Absolutely, Sharon! Thank you so much! 🙂

  2. Nicole says

    Do you feel balloon pumps falling out of favor for treatment of carciogenic shock?

    1. Rishi says

      I don’t think balloon pumps will fall out entirely quite yet due to the ease of their placement and literature in the last five years showing no significant difference in major adverse outcomes in the short-term (~1 month) time frame (ie, PROTECT 2 trial). The cost difference in the devices is astronomical, but one could argue that in the long term, the true costs are equatable. Time will tell. 🙂

  3. Matt says

    Could you comment further on the use of impella for LV vent while on (presumably) VA ECMO?

    1. Rishi says

      So there are several reasons for the LV to be overloaded during V-A ECMO like afterload alterations, aortic insufficiency, collateral bronchial flow, and right heart recovery. Inadequate LV unloading is a fairly common reason for failed ventricular recovery during ECMO. Impella offers one (very expensive) solution to empty the LV.